Healthcare Press

Kura Oncology's stock soars toward record high after trial of lymphoma treatment achieves goal

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Kura Oncology stock soars toward record high after lymphoma drug achieves goal

Shares of Kura Oncology Inc.

soared 27% toward a record high in premarket trading Friday, after the biopharmaceutical company announced a phase 2 trial of its lymphoma treatment achieved its primary efficacy endpoint. The stock was on track to open above its March 2, 2018 record close of $23.40.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

'Stranger Things'' Hawkins High Is Getting the Nike TreatmentNike is redesigning its timeless Cortez, Blazer Mid, Air Tailwind 79 sneakers to honor of Stranger Things 3 upcoming release.
Source: ELLE Magazine (US) - 🏆 472. / 51 Read more »